EN DE ES FR IT Primary Menu Primex Pharmaceuticals Primex Pharmaceuticals is a leading global innovative anaesthesia company, expanding in paediatric pharmaceuticals. Primex brings a broad portfolio of anaesthesia products helping patients undergo a wide range of medical procedures, including a novel, oral solution for paediatric sedation now approved in several markets in the European Union. Primex Pharmaceuticals will continue to identify and bring to the market new medications that complete the Triad of Anaesthesia. In addition, the Group includes a complimentary range of local anaesthetics and dental products under the OGNA® brand. Primex Pharmaceuticals’ global partner network operates in over 40 countries. The company is headquartered in Switzerland; all Primex products are manufactured in Europe. Primex Pharmaceuticals has proven underlying business operations and historical strong revenue growth. Global Strategy Execute our growth plan. Expand partners geographically. Extend Anaesthesia portfolio. Evolve Primex. TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy

EN DE ES FR IT Primary Menu Primex Pharmaceuticals: The leading global ‘commercially focused’ innovative Anaesthesia company Portfolio Strategy 2021 - 2026 Launch OZALIN. Expand geographically with established products: RECOFOL & OGNA. Extend portfolio via new indications and acquisitions to strengthen ‘Triad’ of Anaesthesia. Existing Primex Product Portfolio Recofol (propofol): Recofol N – propofol with MCT/LCT formulation. Recofol EDTA – propofol plus EDTA. Propofo VET – propofol for animals. OZALIN / OZASED* (2mg/ml oral midazolam solution): ADV6209 was the former name of the product. Licensed and approved for paediatric premedication and procedural sedation in the EU, UK and CH. OGNA Dental Portfolio: Local Anaesthetic Portfolio – articaine, mepivicaine and lidocaine (spray & gel). Endodontic Medical Devices (CE marked). TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy

EN DE ES FR IT Primary Menu Primex Historical Development STRONG GROWTH ACHIEVED SINCE INCEPTION IN 2010 Primex is a fast-growing, lean, specialty global pharmaceutical company Broad portfolio of specialty products Scalable business model Experienced senior management and regulatory teams Unique global niche strategy Lean commercially focused organisation Multiple avenues for growth and value creation Global distribution network TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy

EN DE ES FR IT Primary Menu Strategic pipeline pillars Further add-on acquisitions to strengthen the Triad of Anaesthesia. Continue geographical expansion and utilize established network to promote new products. Extend product portfolio through new indications and new formulations focusing on paediatrics. TOP © 2018 Primex Pharmaceuticals. All Rights Reserved. Privacy Policy | Conditions of Use | Drug Safety Reporting Privacy Policy